Provide Parkinson genetic testing results
- Trial ID
- NCT04994015
- Official Title
- Parkinson's Foundation PD GENEration Genetic Registry
- Goal
- Provide Parkinson genetic testing results
- Status
- RECRUITING
- Sponsor
- Parkinson's Foundation
- Study Type
- OBSERVATIONAL
- Enrollment
- 25000 participants
- Conditions
- Parkinson's Disease
- Interventions
- Lab Assay for seven genetic variants for Parkinson's Disease
Plain-Language Summary
The goal is to build a large genetic registry to find Parkinson's-linked gene changes and help match people to gene-focused research, understand how genetics affect symptoms, and guide future care. The approach is a lab genetic test that looks for variants in seven PD-related genes, GBA, LRRK2, SNCA, VPS35, PRKN, PINK1, and PARK7, and participants can choose to be told their results; this is observational, it does not change your medications. The project can also invite family members for confirmatory testing when needed. Adults 18 and older with a probable Parkinson's diagnosis who can give informed consent and complete surveys are eligible, while people with atypical parkinsonism, recent blood transfusion, active blood cancers, or recent bone marrow transplant are excluded.
Locations
- University of Alabama Birmingham, Birmingham, Alabama, United States
- MD First Research, Chandler, Arizona, United States
- Barrow Neurological Institute, Phoenix, Arizona, United States
- University of Arkansas, Fayetteville, Arkansas, United States
- University of California San Diego (UCSD), La Jolla, California, United States
- University of California Los Angeles, Los Angeles, California, United States
- University of California San Francisco (UCSF), San Francisco, California, United States
- University of Colorado Anschutz, Aurora, Colorado, United States
- Hartford Healthcare, Hartford, Connecticut, United States
- Aventura Neurology - Visionary Investigators Network, Aventura, Florida, United States
- Parkinson's Disease & Movement Disorder Center of Boca Raton, Boca Raton, Florida, United States
- University of Florida, Gainesville, Florida, United States
- University of Miami, Miami, Florida, United States
- Cleveland Clinic Weston, Weston, Florida, United States
- Morehouse College, Atlanta, Georgia, United States
- The Queen's Health System, Honolulu, Hawaii, United States
- University of Illinois-Chicago, Chicago, Illinois, United States
- Rush University, Chicago, Illinois, United States
- University of Chicago, Chicago, Illinois, United States
- Northwestern University, Evanston, Illinois, United States
And 36 more locations.
Frequently Asked Questions
- What is this trial testing?
- This trial is studying Lab Assay for seven genetic variants for Parkinson's Disease. The goal is to build a large genetic registry to find Parkinson's-linked gene changes and help match people to gene-focused research, understand how genetics affect symptoms, and guide future care. The approach is a lab genetic test that looks for variants in seven PD-related genes, GBA, LRRK2, SNCA, VPS35, PRKN, PINK1, and PARK7, and participants can choose to be told their results; this is observational, it does not change your medications. The project can also invite family members for confirmatory testing when needed. Adults 18 and older with a probable Parkinson's diagnosis who can give informed consent and complete surveys are eligible, while people with atypical parkinsonism, recent blood transfusion, active blood cancers, or recent bone marrow transplant are excluded.
- Who can participate?
- Participants must be at least 18 Years.
- Where is this trial located?
- This trial is recruiting at 56 locations.
- Does it cost anything to join?
- No. There is no cost to participate. Study-related care and treatment are provided at no charge.
- How long does the trial last?
- This trial is estimated to last approximately 5 years and 6 months.